Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial
Live zoster vaccination significantly reduced the incidence of chronic respiratory disease and related hospitalizations. These findings suggest that live zoster vaccination may provide public health benefits beyond preventing herpes zoster in adults aged ≥ 50 years.
Authors
- Jaehyeong Cho (ORCID: https://orcid.org/0009-0008-7892-3741)
- Kyeongmin Lee (ORCID: https://orcid.org/0009-0004-0379-2151)
- Dong Keon Yon (ORCID: https://orcid.org/0000-0003-1628-9948)
- Junyang Jung (ORCID: https://orcid.org/0000-0003-3946-5406)
- Lee Smith (ORCID: https://orcid.org/0000-0002-5340-9833)
- T.H. Kim
- Francesco Branda (ORCID: https://orcid.org/0000-0002-9485-3877)
- Ha-Yeon Lee (ORCID: https://orcid.org/0000-0003-4648-586X)
- Jinseok Lee (ORCID: https://orcid.org/0000-0002-8580-490X)
- Sooji Lee (ORCID: https://orcid.org/0009-0002-1413-378X)
- Jiyeon Oh (ORCID: https://orcid.org/0009-0005-3291-4370)
Institutions
- Università Campus Bio-Medico (IT)
- Kyung Hee University (KR)
- Biruni University (TR)
- Kyung Hee University Medical Center (KR)
- CHA University (KR)
- Anglia Ruskin University (GB)
Publication Details
- Journal
- Allergy
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/all.70056
- Citations
- 4
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.42